Two isoforms of tissue transglutaminase mediate opposing cellular fates. - Wikidata - wikimedia - TriplyDB

Two isoforms of tissue transglutaminase mediate opposing cellular fates.

Two isoforms of tissue transglutaminase mediate opposing cellular fates.

http://www.wikidata.org/entity/Q35157424

about

Transglutaminase 2 has opposing roles in the regulation of cellular functions as well as cell growth and death Protein transamidation by transglutaminase 2 in cells: a disputed Ca2+-dependent action of a multifunctional protein Cellular functions of tissue transglutaminase Role of transglutaminase 2 in celiac disease pathogenesis Transglutaminase 6: a protein associated with central nervous system development and motor function.Identification of two GTP-independent alternatively spliced forms of tissue transglutaminase in human leukocytes, vascular smooth muscle, and endothelial cells.Intracellular localization and conformational state of transglutaminase 2: implications for cell death.Transglutaminase 2, a novel regulator of eicosanoid production in asthma revealed by genome-wide expression profiling of distinct asthma phenotypes Opposing effects of two tissue transglutaminase protein isoforms in neuroblastoma cell differentiation.TGM2: a cell surface marker in esophageal adenocarcinomas.Type 2 transglutaminase in Huntington's disease: a double-edged sword with clinical potential.Transglutaminase 2: a molecular Swiss army knife.Tissue transglutaminase: a new target to reverse cancer drug resistance Regulation of the activities of the mammalian transglutaminase family of enzymes.Extracellular tissue transglutaminase activates noncanonical NF-κB signaling and promotes metastasis in ovarian cancer The Different Conformational States of Tissue Transglutaminase Have Opposing Affects on Cell Viability.Tissue transglutaminase protects epithelial ovarian cancer cells from cisplatin-induced apoptosis by promoting cell survival signaling.Role of transglutaminase 2 in liver injury via cross-linking and silencing of transcription factor Sp1 Extracellular matrix modifications at fertilization: regulation of dityrosine crosslinking by transamidation.Transglutaminase activation in neurodegenerative diseases.Recent advances in understanding the roles of transglutaminase 2 in alcoholic steatohepatitis.Evidences for a role of protein cross-links in transglutaminase-related disease.Transglutaminase as a therapeutic target for celiac disease.miR-19-Mediated Inhibition of Transglutaminase-2 Leads to Enhanced Invasion and Metastasis in Colorectal Cancer.Interplay between transglutaminases and heparan sulphate in progressive renal scarring.Expression of transglutaminase-2 isoforms in normal human tissues and cancer cell lines: dysregulation of alternative splicing in cancer.Cystamine suppresses polyalanine toxicity in a mouse model of oculopharyngeal muscular dystrophy.GTP-binding-defective forms of tissue transglutaminase trigger cell death.Calcium-dependent activation of transglutaminase 2 by nanosecond pulsed electric fields.The Differential Effects of R580A Mutation on Transamidation and GTP Binding Activity of Rat and Human Type 2 Transglutaminase.Carbon monoxide modulates alpha-smooth muscle actin and small proline rich-1a expression in fibrosis Transglutaminase 2 facilitates or ameliorates HIF signaling and ischemic cell death depending on its conformation and localization.Transglutaminases: future perspectives.Tissue transglutaminase in astrocytes is enhanced by inflammatory mediators and is involved in the formation of fibronectin fibril-like structures.Deletion of 8q24 in an adult with mild dysmorphic features, developmental delay, and ketotic hypoglycemia.Role and predictive strength of transglutaminase type 2 expression in premalignant lesions of the cervix.Biological functionalities of transglutaminase 2 and the possibility of its compensation by other members of the transglutaminase family.

P2860

Q28069852-EAAFF552-FA2B-4C2E-9A4B-2C0F38863ACD Q28247511-29477AAB-7A86-45B1-BFEF-20783B6EF8B1 Q28260600-509FC553-473F-462A-A698-EEEB7FD5D1C6 Q28262529-9B8266B2-7863-4FFB-89E0-78FA52D8D981 Q30155456-CB12AF9E-481D-4919-9AB4-95F280497A1F Q33289840-908A33D4-FBD8-49B0-BEDB-0DD2BD609F66 Q33476870-37A87918-E09C-4E23-A9F2-BFEB25FF36EC Q33522235-7371EF5D-0BE4-4465-B14A-9CE8882851B1 Q33661950-48339D1F-51F7-4511-B6D5-D2F149C698EA Q34219975-F3EC97DA-43CB-4690-B13A-6632A9B65358 Q34775357-C5DAD1F9-C100-4893-93F1-63CD9CC75369 Q35693361-3639A4C2-D967-415D-81E6-F02D3C344D90 Q36503511-66EDCB9B-CC0E-47B9-BEFE-31B76B2FC473 Q36620140-2DCBCB43-C4D7-45B9-8652-A594AA19D808 Q36879220-DE1BBA7D-B374-4711-9DE5-221F4D27A166 Q36884822-4E1B2E66-890D-420D-85E9-80A35DB27E37 Q36916874-D1758AEB-B862-4BF6-BFF4-F36F6F58FB1E Q37124999-363C4A5B-C6C3-482F-9401-CEC4A1329925 Q37186873-24078DEE-A0A0-4419-8680-B2821FBFCC26 Q37352964-CDEB3F53-DA04-4EDF-A726-C8500DE37CF5 Q37700761-0BD13721-A178-437E-880C-68D85933AF30 Q37907975-BAF2353E-F61C-4E2D-92F0-7D79EF5EC277 Q38269678-22BDE123-00CC-4D4A-A9AA-FE727ABF2EEC Q38879949-973F611F-9BA3-4D8B-9885-8797D8B3BF53 Q39330237-C2DC6807-7B57-41E9-93B1-CBE3BCF4D13F Q39442011-F8E4DCDB-49BF-47EC-BFE3-B6B1DFE61DE9 Q39697142-72FF2E48-AB2C-4F17-8EB1-ED6596574D20 Q40041960-C86B5E0E-21FE-4ABF-999A-018502A2DED1 Q40981694-ADD64612-7C25-4E33-8E37-7322C18F061A Q41418352-D0A7E60C-EB47-4457-83CB-E6AABFDC3620 Q41975551-912A03E4-317F-420F-95F4-7723AFA98FD2 Q42403952-74B2F4F6-712C-46F8-A010-5B777D9457A7 Q44811427-61B9B8F7-6DCE-4C1E-8FBF-58F237E094C7 Q47099586-7A336EDC-B14D-400F-9F0F-A2546B77CA73 Q51907616-3E31A481-4BD7-4C3A-86AD-A734C0655611 Q54600809-58CD4EEF-DF2A-45D2-B435-36205D596A07 Q55499802-8F76D248-D9E6-4E60-8511-2178AE349651

P2860

Two isoforms of tissue transglutaminase mediate opposing cellular fates.

http://www.wikidata.org/entity/Q35157424

description

2006 nî lūn-bûn

@nan

2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Two isoforms of tissue transglutaminase mediate opposing cellular fates.

@ast

Two isoforms of tissue transglutaminase mediate opposing cellular fates.

@en

type

label

Two isoforms of tissue transglutaminase mediate opposing cellular fates.

@ast

Two isoforms of tissue transglutaminase mediate opposing cellular fates.

@en

prefLabel

Two isoforms of tissue transglutaminase mediate opposing cellular fates.

@ast

Two isoforms of tissue transglutaminase mediate opposing cellular fates.

@en

P1433

Q35157424-6996CBA8-2CFF-4AF2-91D4-3B111BBDCD05

P1476

Q35157424-B64706F7-5B33-4DCF-A656-A17EFB7CA177

P2093

Q35157424-15BB06CF-AA85-41C8-B297-CD7A0EE9A7A0

Q35157424-32F3F443-744F-41B0-99EC-12C06F9BD8B0

Q35157424-524FF4AC-C5A1-4332-8AF0-EDD380FC04AE

Q35157424-5B2C5468-7C9E-4F19-8887-0469A41F11E3

Q35157424-89708A0D-34D0-4EA7-8BF6-B6C95FA35963

Q35157424-C9315DC9-31EF-448D-9718-E8AF1C8D7638

P2860

Q35157424-05FFF936-3ECD-485A-BC11-19D55323FEBD

Q35157424-0ACE5FF8-B2E1-4773-8770-F6B7D91EDDD8

Q35157424-132C2E58-306E-45F0-9953-8432FD76ADFE

Q35157424-13B1B1C9-E2F8-44F1-BB79-D2C462E5236D

Q35157424-1477CF31-AD82-416C-BEAA-41FA4350AC2F

Q35157424-20C56651-060A-484E-A5B3-27506AB7314F

Q35157424-4762419B-62B5-4BED-8F89-98E7F84B7EF5

Q35157424-52902F8F-6310-4E3C-81E6-5D08EF83D138

Q35157424-53C0E037-CF9A-4892-8EE9-022071713EC1

Q35157424-54B0E645-D65A-4B6A-BB84-9E3C1513E32F

P304

Q35157424-58DB0053-8532-4BC0-A1F8-3149B9EAE066

P31

Q35157424-0FB36667-527F-403E-82AF-E6F71133FC35

P356

Q35157424-F594FDCE-31F6-460F-9AAB-DD62C12CD5B8

P407

Q35157424-45CE5E3D-1D5B-4B7E-BE6A-8211B830E1F1

P433

Q35157424-C77F2631-DD76-4C6F-8594-62950E4085F7

P478

Q35157424-51B78D19-91D6-4D88-91CC-E91581B3DFF0

P577

Q35157424-AFA6B321-E50A-46F9-96F2-8EF9D65661BB

P5875

Q35157424-434CD87E-8ECB-4B2C-86F7-BAA146E275B1

P698

Q35157424-6034182D-587E-4A0E-BAC9-31171E043F14

P932

Q35157424-8D8D0217-788E-41D0-B4AE-59171DA16CBD

P356

PNAS.0604844103

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Two isoforms of tissue transglutaminase mediate opposing cellular fates.

@en

P2093

Allison M Miller

http://www.w3.org/2001/XMLSchema#string

Jaclyn M Jansen

http://www.w3.org/2001/XMLSchema#string

Makoto Endo

http://www.w3.org/2001/XMLSchema#string

Marc A Antonyak

http://www.w3.org/2001/XMLSchema#string

Richard A Cerione

http://www.w3.org/2001/XMLSchema#string

Thi K Ly

http://www.w3.org/2001/XMLSchema#string

P2860

Transglutaminases: nature's biological glues

Differential expression of multiple transglutaminases in human brain. Increased expression and cross-linking by transglutaminases 1 and 2 in Alzheimer's disease

Identification of differentially expressed proteins in human glioblastoma cell lines and tumors.

Tissue transglutaminase is essential for neurite outgrowth in human neuroblastoma SH-SY5Y cells.

Tissue transglutaminase-induced aggregation of alpha-synuclein: Implications for Lewy body formation in Parkinson's disease and dementia with Lewy bodies.

Transglutaminases: crosslinking enzymes with pleiotropic functions.

Transglutaminase 2 in the balance of cell death and survival.

Transglutaminase aggregates huntingtin into nonamyloidogenic polymers, and its enzymatic activity increases in Huntington's disease brain nuclei.

Mutation of a critical arginine in the GTP-binding site of transglutaminase 2 disinhibits intracellular cross-linking activity.

Implications of increased tissue transglutaminase (TG2) expression in drug-resistant breast cancer (MCF-7) cells.

P304

18609-18614

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0604844103

http://www.w3.org/2001/XMLSchema#string

P407

P433

49

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P577

2006-11-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6680860

http://www.w3.org/2001/XMLSchema#string

P698

17116873

http://www.w3.org/2001/XMLSchema#string

P932

1654133

http://www.w3.org/2001/XMLSchema#string